PARVULET Trademark

Trademark Overview


On Thursday, September 1, 2005, a trademark application was filed for PARVULET with the United States Patent and Trademark Office. The USPTO has given the PARVULET trademark a serial number of 78705641. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 3, 2019. This trademark is owned by EGALET A/S. The PARVULET trademark is filed in the Pharmaceutical Products, Medical Instrument Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and veterinary preparations for the treatment of pain relief and pain management, shock, hemorrhage and bleeding, pre- and post-operative complications in the nature of hemorrhage, bleeding, thrombosis, emboli, stroke, apoplexy, lesions, respiratory and circulatory crises and dysfunctions, cognitive dysfunctions, fibrosis, infections, fever and sepsis, and traumas and emergencies, namely, fractures, abrasions, burns, psychological and immunological shock, poisons and pollutions, animal bites or stings, fever, respiratory and cardiovascular shock, crises and dysfunctions, and hemorrhage, bleeding, thrombosis, emboli, stroke, apoplexy, lesions and cognitive dysfunctions, and physical and psychological substance dependence, namely, drug and alcohol dependence, drug tolerance, withdrawal symptoms, convulsions, Alzheimer disease, dementias, Parkinson's disease, insufficient saliva and inability to swallow, allergy/immunology disorders, burns, diseases of the heart and blood v...

Surgical, medical, dental and veterinary apparatus and instruments, namely, drug delivery apparatus and instruments in the form of containers for various pharmaceuticals, drugs, medicines, compounds and substances in the form of liquids, gels, grains, emulsions, blister packs and sachets; spoons, cups and syringes for administering pharmaceutical substances and medicines; drug delivery systems

Treatment of materials, namely, milling, mixing, grinding, liquefying, pulverizing, melting and extrusion of medical and pharmaceutical substances, compounds and materials

Scientific research; technology consultation in the field of scientific research; design for others in the fields of pain relief and pain management, pharmaceutical drug and medicine development, development of medicines and medicine goods and packaging in the fields of traumas and emergencies, addictions, aging, allergy/immunology, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, diseases in the obstetrical- and gynecological field, occupational diseases and afflictions, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear-nose and throat, diseases and afflictions on t...
parvulet

General Information


Serial Number78705641
Word MarkPARVULET
Filing DateThursday, September 1, 2005
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 3, 2019
Registration Number4215867
Registration DateTuesday, October 2, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 2, 2009

Trademark Statements


Goods and ServicesPharmaceutical and veterinary preparations for the treatment of pain relief and pain management, shock, hemorrhage and bleeding, pre- and post-operative complications in the nature of hemorrhage, bleeding, thrombosis, emboli, stroke, apoplexy, lesions, respiratory and circulatory crises and dysfunctions, cognitive dysfunctions, fibrosis, infections, fever and sepsis, and traumas and emergencies, namely, fractures, abrasions, burns, psychological and immunological shock, poisons and pollutions, animal bites or stings, fever, respiratory and cardiovascular shock, crises and dysfunctions, and hemorrhage, bleeding, thrombosis, emboli, stroke, apoplexy, lesions and cognitive dysfunctions, and physical and psychological substance dependence, namely, drug and alcohol dependence, drug tolerance, withdrawal symptoms, convulsions, Alzheimer disease, dementias, Parkinson's disease, insufficient saliva and inability to swallow, allergy/immunology disorders, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases in the nature of flu, AIDS/HIV, anthrax, plague, cholera, biological infections, and prion exposure, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, genitourinary diseases and afflictions, premature labor, poison exposure, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and throat, diseases and afflictions on the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions, veterinary preparations for the treatment of bovine, sheep, horses, pigs, poultry, ostrich, rodents, dogs, cats, camels, donkeys, elephants; dietetic food adapted for medical use; diagnostic preparations for medical and veterinary use; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; synthetic peptides for pharmaceutical purposes; vitamins; biomedical compounds, namely, peptide substrates for use in analyzing and detecting toxins for medical laboratory use; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets, oral liquids, oral gels, and oral emulsions for the continuous release of a wide variety of therapeutic agents within a certain time after ingestion; medicated candy; medicated chewing gum; breath-freshening chewing gum for medical purposes; medicated lollipops; sweets for medicinal purposes, namely, sweets containing pharmaceutical and medical substances and compounds
Goods and ServicesSurgical, medical, dental and veterinary apparatus and instruments, namely, drug delivery apparatus and instruments in the form of containers for various pharmaceuticals, drugs, medicines, compounds and substances in the form of liquids, gels, grains, emulsions, blister packs and sachets; spoons, cups and syringes for administering pharmaceutical substances and medicines; drug delivery systems
Goods and ServicesTreatment of materials, namely, milling, mixing, grinding, liquefying, pulverizing, melting and extrusion of medical and pharmaceutical substances, compounds and materials
Goods and ServicesScientific research; technology consultation in the field of scientific research; design for others in the fields of pain relief and pain management, pharmaceutical drug and medicine development, development of medicines and medicine goods and packaging in the fields of traumas and emergencies, addictions, aging, allergy/immunology, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, diseases in the obstetrical- and gynecological field, occupational diseases and afflictions, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear-nose and throat, diseases and afflictions on the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions, veterinary preparations for the treatment of bovine, sheep, horses, pigs, poultry, ostrich, rodents, dogs, cats, camels, donkeys, elephants; chemical, biochemical, biological and bacteriological research and analysis; pharmaceutical drug and medicine development services; design for others in the field of drugs and medicines; development of pharmaceutical preparations and medicines; professional consultancy pertaining to pharmacology, namely, biotechnical and biomedical and medical and pharmaceutical substances, preparations and compounds; professional consultancy in the field of research and development of medicine and the dispensing of pharmaceutical preparations; pharmaceutical drug development services comprised of scientific, industrial, technological, bio technical, pharmaceutical, biomedical and clinical research in the field of drugs and drug candidates; medical and scientific research, namely, conducting clinical trials of new drug candidates; consultation in the field of scientific research pertaining to chemical, pharmaceutical and medical goods; design for others in the field of medical packaging and equipment; development of pharmaceutical preparations and medicines; consultation in the field of biotechnological and biomedical scientific research; biochemical and molecular biological analyses; in vitro and in vivo preclinical tests and clinical tests of drug candidates and potential drugs; consultancy and research regarding pharmaceuticals in gel-like and viscous liquid dosage forms; consultancy and research pertaining to pharmacology in the nature of alternative drugs for the young, elderly and those with difficulties swallowing pills and tablets; development of in vitro and in vivo preclinical tests of drug candidates and potential drugs; biochemical and molecular biological analyses; scientific, industrial, technological and biotechnological analysis in the field of pharmaceutical and veterinary drug and medicine analysis, analysis of drug delivery apparatus and containers, analysis of synthetic peptides for pharmaceutical purposes, analysis of peptide substrates, analysis for the purpose of detecting various toxins, analysis of drug candidates and potential drugs

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 3, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 3, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 3, 2019
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 3, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameADARE PHARMACEUTICALS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressLAWRENCEVILLE, NJ 08648

Party NameEGALET LTD
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLONDON EC4V4QQ
GB

Party NameEGALET LTD
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressLONDON W1S 2LQ
GB

Party NameEGALET A/S
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKirke Værløse 3500
DK

Party NameEGALET A/S
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKirke Værløse 3500
DK

Trademark Events


Event DateEvent Description
Wednesday, July 31, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, May 3, 2019CANCELLED SEC. 8 (6-YR)
Monday, October 2, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, September 14, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 14, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 2, 2012REGISTERED-PRINCIPAL REGISTER
Wednesday, August 29, 20121(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, August 15, 2012NOTICE OF ALLOWANCE CANCELLED
Wednesday, August 15, 2012TEAS DELETE 1(B) BASIS RECEIVED
Wednesday, February 22, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 21, 2012EXTENSION 5 GRANTED
Friday, February 10, 2012EXTENSION 5 FILED
Friday, February 10, 2012TEAS EXTENSION RECEIVED
Tuesday, August 23, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, August 20, 2011EXTENSION 4 GRANTED
Wednesday, August 17, 2011EXTENSION 4 FILED
Wednesday, August 17, 2011TEAS EXTENSION RECEIVED
Saturday, February 26, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 25, 2011EXTENSION 3 GRANTED
Wednesday, February 23, 2011EXTENSION 3 FILED
Wednesday, February 23, 2011TEAS EXTENSION RECEIVED
Wednesday, October 13, 2010AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, September 9, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 8, 2010EXTENSION 2 GRANTED
Monday, August 23, 2010EXTENSION 2 FILED
Monday, August 23, 2010TEAS EXTENSION RECEIVED
Saturday, January 30, 2010EXTENSION 1 GRANTED
Monday, December 21, 2009EXTENSION 1 FILED
Friday, January 29, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 21, 2009TEAS EXTENSION RECEIVED
Tuesday, August 25, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 2, 2009PUBLISHED FOR OPPOSITION
Wednesday, May 13, 2009NOTICE OF PUBLICATION
Tuesday, April 28, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, April 27, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, April 4, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, April 4, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 1, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 8, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 8, 2008NON-FINAL ACTION E-MAILED
Wednesday, October 8, 2008NON-FINAL ACTION WRITTEN
Friday, September 12, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 12, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 11, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 11, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 11, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 11, 2008NON-FINAL ACTION E-MAILED
Tuesday, March 11, 2008NON-FINAL ACTION WRITTEN
Wednesday, February 6, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 5, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 5, 2008TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, November 26, 2007NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, November 26, 2007INQUIRY TO SUSPENSION E-MAILED
Monday, November 26, 2007SUSPENSION INQUIRY WRITTEN
Tuesday, November 6, 2007LIE CHECKED SUSP - TO ATTY FOR ACTION
Friday, May 4, 2007REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, May 4, 2007ASSIGNED TO LIE
Wednesday, October 25, 2006LETTER OF SUSPENSION E-MAILED
Wednesday, October 25, 2006SUSPENSION LETTER WRITTEN
Tuesday, October 3, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 3, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 2, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 2, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 30, 2006NON-FINAL ACTION E-MAILED
Thursday, March 30, 2006NON-FINAL ACTION WRITTEN
Thursday, March 16, 2006ASSIGNED TO EXAMINER
Monday, February 27, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 15, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 15, 2006TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, September 9, 2005NEW APPLICATION ENTERED IN TRAM